Abstract
Cell proliferation and malignant transformation are enabled by genetic and epigenetic changes. During the malignancy process, malignant cells acquire distinguishing characteristics. Cancer cells have acquired the ability to generate more reactive oxygen species (ROS), resulting in high oxidative stress. ROS-mediated signaling is needed for cancer cell physiology, and high levels of ROS cause oxidative stress-induced cytotoxicity in cancer cells. To avoid ROS-mediated cytotoxicity, cancer cells modulate their redox state through various antioxidant mechanisms and keep their ROS levels below the threshold. Cancer treatment that targets oxidative stress is an appealing option. Many natural oxidative stress modulators and bioactive compounds have been used in the treatment of cancer. Conventional uptake of bioactive molecule is associated with lower bioavailability, solubility, unlikely biodistribution, and side effects. Traditional drug uptake is improved by nanoformulation, making it easier to overcome side effects, improve biodistribution, and extend drug duration time. Natural prooxidant-loaded nanoparticles efficiently carry prooxidant to the tumor site and selectively and efficiently induce oxidative stress-mediated cell death in cancer cells.
Similar content being viewed by others
References
Aggarwal BB (2000) Apoptosis and nuclear factor-κB: a tale of association and dissociation. Biochem Pharmacol 60(8):1033–1039
Ahmed S, Kaur G, Sharma P, Singh S, Ikram S (2018) Fruit waste (peel) as bio-reductant to synthesize silver nanoparticles with antimicrobial, antioxidant and cytotoxic activities. J Appl Biomed 16(3):221–231
Alfei S, Marengo B, Zuccari G, Turrini F, Domenicotti C (2020) Dendrimer nanodevices and gallic acid as novel strategies to fight chemoresistance in neuroblastoma cells. Nano 10(6):1243
Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205–214
Bedard K, Krause K-H (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245–313
Bell EL, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Budinger GS, Chandel NS (2007) The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 177(6):1029–1036
Boveris A, Oshino N, Chance B (1972) The cellular production of hydrogen peroxide. Biochem J 128(3):617–630
Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O 2 sensing. J Biol Chem 275:25130–25138
Chang P-Y, Peng S-F, Lee C-Y, Lu C-C, Tsai S-C, Shieh T-M, Wu T-S, Tu M-G, Chen MY, Yang J-S (2013) Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. Int J Oncol 43(4):1141–1150
Chapman E, Zhang D (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34(1):21–43
Chatterjee S, Browning EA, Hong N, DeBolt K, Sorokina EM, Liu W, Birnbaum MJ, Fisher AB (2012) Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am J Phys Heart Circ Phys 302(1):H105–H114
Choi DG, Venkatesan J, Shim MS (2019) Selective anticancer therapy using pro-oxidant drug-loaded chitosan–fucoidan nanoparticles. Int J Mol Sci 20(13):3220
Collaboration GB o DC (2015) Novel methods for measuring global cancer burden. JAMA Oncol 1(4):505–527
Da Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1(4):364–369
Di Meo SR, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxidative Med Cell Longev 2016:1245049
Donadelli M, Dando I, Zaniboni T, Costanzo C, Dalla Pozza E, Scupoli M, Scarpa A, Zappavigna S, Marra M, Abbruzzese A (2011) Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis 2(4):e152–e152
Enslen H, Tokumitsu H, Stork P, Davis RJ, Soderling TR (1996) Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci 93(20):10803–10808
Ferro E, Goitre L, Retta SF, Trabalzini L (2012) The interplay between ROS and Ras GTPases: physiological and pathological implications. J Signal Transduct 2012:365769
Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Investig J Tech Meth Pathol 47(5):412–426
García-Fernández LF, Losada A, Alcaide V, Alvarez AM, Cuadrado A, González L, Nakayama K, Nakayama KI, Fernández-Sousa JM, Muñoz A (2002) Aplidin™ induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C δ. Oncogene 21(49):7533–7544
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Hang W, Yin Z-X, Liu G, Zeng Q, Shen X-F, Sun Q-H, Li D-D, Jian Y-P, Zhang Y-H, Wang Y-S (2018) Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Oncogene 37(25):3384–3398
Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39(4):199–218
Hayes JD, Dinkova-Kostova AT, Tew KD (2020) Oxidative stress in cancer. Cancer Cell 38(2):167–197
Hou G-X, Liu P-P, Zhang S, Yang M, Liao J, Yang J, Hu Y, Jiang W-Q, Wen S, Huang P (2018) Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis. Cell Death Dis 9(2):1–15
Iqbal J, Abbasi B, Mahmood T, Kanwal S, Ali B, Shah S (2017) Plant-derived anticancer agents: A green anticancer approach. Asian Pac J Trop Biomed 7(12):1129–1150
Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275(5306):1649–1652
Kansanen E, Kuosmanen SM, Leinonen H, Levonen A-L (2013) The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1(1):45–49
Karthik L, Kumar G, Keswani T, Bhattacharyya A, Chandar SS, Bhaskara Rao K (2014) Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLoS One 9(3):e90972
Khan M, Ma T (2017) Is oxidative stress in cancer cells a real therapeutic target. Clin Oncol 2:1221
Kim W, Lee S, Seo D, Kim D, Kim K, Kim E, Kang J, Seong KM, Youn H, Youn B (2019a) Cellular stress responses in radiotherapy. Cell 8(9):1105
Kim Y-S, Kim S, Kang HC, Shim MS (2019b) ROS-responsive thioether-based nanocarriers for efficient pro-oxidant cancer therapy. J Ind Eng Chem 75:238–245
Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P (1996) Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15(19):5314–5325
Koboldt D, Fulton R, McLellan M, Schmidt H, Kalicki-Veizer J, McMichael J, Fulton L, Dooling D, Ding L, Mardis E (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70
Koundouros N, Poulogiannis G (2018) Phosphoinositide 3-kinase/Akt signaling and redox metabolism in cancer. Front Oncol 8:160
Krumova K, Cosa G (2016) Overview of reactive oxygen species. In: Singlet oxygen: applications in biosciences and nanosciences, vol vol 1. RSC, pp 1–21. https://doi.org/10.1039/9781782622208-00001
Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, Quilliam LA (1997) A molecular redox switch on p21ras: structural basis for the nitric oxide-p21ras interaction. J Biol Chem 272(7):4323–4326
Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu Z-X, Ferrans VJ, Howard BH, Finkel T (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274(12):7936–7940
Lee JK, Edderkaoui M, Truong P, Ohno I, Jang KT, Berti A, Pandol SJ, Gukovskaya AS (2007) NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 133(5):1637–1648
León-González AJ, Auger C, Schini-Kerth VB (2015) Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol 98(3):371–380
Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278(10):8516–8525
Li Y, Yang J, Sun X (2021) Reactive oxygen species-based nanomaterials for cancer therapy. Front Chem 9:152
Lin C-J, Lee C-C, Shih Y-L, Lin C-H, Wang S-H, Chen T-H, Shih C-M (2012) Inhibition of mitochondria-and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One 7(6):e38706
Lu J, Sharma LK, Bai Y (2009) Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19(7):802–815
Maciag A, Sithanandam G, Anderson LM (2004) Mutant K-ras V12 increases COX-2, peroxides and DNA damage in lung cells. Carcinogenesis 25(11):2231–2237
Matsukawa J, Matsuzawa A, Takeda K, Ichijo H (2004) The ASK1-MAP kinase cascades in mammalian stress response. J Biochem 136(3):261–265
McCubrey JA, LaHair MM, Franklin RA (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8(9–10):1775–1789
Mirza AZ, Siddiqui FA (2014) Nanomedicine and drug delivery: a mini review. Int Nano Lett 4(1):94
Mitsushita J, Lambeth JD, Kamata T (2004) The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 64(10):3580–3585
Morgan MJ, Liu Z-G (2011) Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21(1):103–115
Mukhtar M, Bilal M, Rahdar A, Barani M, Arshad R, Behl T, Brisc C, Banica F, Bungau S (2020) Nanomaterials for diagnosis and treatment of brain cancer: recent updates. Chemosensors 8(4):117
Naqvi S, Panghal A, Flora S (2020) Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front Neurosci 14:494
Panieri E, Santoro M (2016) ROS homeostasis and metabolism: a dangerous liaison in cancer cells. Cell Death Dis 7(6):e2253–e2253
Park S-A, Na H-K, Kim E-H, Cha Y-N, Surh Y-J (2009) 4-Hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IκB kinase: potential role of reactive oxygen species. Cancer Res 69(6):2416–2424
Park M, Kim M, Suh Y, Kim R, Kim H, Lim E, Yoo K, Lee G, Kim Y, Hwang S (2014) Novel signaling axis for ROS generation during K-Ras-induced cellular transformation. Cell Death Differ 21(8):1185–1197
Parks DA, Williams TK, Beckman JS (1988) Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol Gastrointest Liver Physiol 254(5):G768–G774
Patra JK, Das G, Fraceto LF, Campos EVR, del Pilar Rodriguez-Torres M, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):1–33
Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, Keating MJ, Huang P (2003) Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278(39):37832–37839
Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192–203
Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4(2):89
Phaniendra A, Jestadi DB, Periyasamy L (2015) Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem 30(1):11–26
Prieto-Bermejo R, Romo-González M, Pérez-Fernández A, Ijurko C, Hernández-Hernández Á (2018) Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side. J Exp Clin Cancer Res 37(1):1–18
Raimondi V, Ciccarese F, Ciminale V (2020) Oncogenic pathways and the electron transport chain: a dangerous liaison. Br J Cancer 122(2):168–181
Salehi B, Azzini E, Zucca P, Maria Varoni E, Anil Kumar NV, Dini L, Panzarini E, Rajkovic J, Valere Tsouh Fokou P, Peluso I (2020) Plant-derived bioactives and oxidative stress-related disorders: a key trend towards healthy aging and longevity promotion. Appl Sci 10(3):947
Sarkar FH, Li Y (2007) NF-κB is a key regulator for oxidative stress, cancer and beyond. Oxford Biomedical Research, Oxford
Schmitt JM, Wayman GA, Nozaki N, Soderling TR (2004) Calcium activation of ERK mediated by calmodulin kinase I. J Biol Chem 279(23):24064–24072
Shan F, Shao Z, Jiang S, Cheng Z (2016) Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways. Cancer Med 5(11):3166–3175
Stehbens WE (2004) Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 77(2):121–132
Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci 10(1–3):1881–1896
Sundaresan M, Yu Z-X, Ferrans VJ, Sulciner DJ, Gutkind S, Irani KJ, Goldschmidt-Clermont PJ, Finkel T (1996) Regulation of reactive-oxygen-species generation in fibroblasts by Rac 1. Biochem J 318(2):379–382
Taguchi K, Yamamoto M (2017) The KEAP1–NRF2 system in cancer. Front Oncol 7:85
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Phys Lung Cell Mol Phys 279(6):L1005–L1028
Thilakarathna SH, Rupasinghe HP (2013) Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5(9):3367–3387
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84
Watkins R, Wu L, Zhang C, Davis RM, Xu B (2015) Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine 10:6055–6074
Whisler RL, Goyette MA, Grants IS, Newhouse YG (1995) Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch Biochem Biophys 319(1):23–35
Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J (2011) Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier. J Control Release 154(1):103–107
Xiao GG, Wang M, Li N, Loo JA, Nel AE (2003) Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 278(50):50781–50790
Xu WT, Shen GN, Li TZ, Zhang Y, Zhang T, Xue H, Zuo WB, Li YN, Zhang DJ, Jin CH (2020) Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROS-regulated MAPK, STAT3 and NF-κB signaling pathways. Int J Oncol 57(2):550–561
Yadav UP, Singh T, Kumar P, Sharma P, Kaur H, Sharma S, Singh S, Kumar S, Mehta K (2020) Metabolic adaptations in cancer stem cells. Front Oncol 10:1010
Yin W, Li J, Ke W, Zha Z, Ge Z (2017) Integrated nanoparticles to synergistically elevate tumor oxidative stress and suppress antioxidative capability for amplified oxidation therapy. ACS Appl Mater Interfaces 9(35):29538–29546
Zamboni W (2007) Carrier-mediated and artificial-cell targeted cancer drug delivery. In: Artificial cells, cell engineering and therapy. Elsevier, pp 469–501
Zhang Q, Ma Y, Cheng Y-F, Li W-J, Zhang Z, Chen S-Y (2011) Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells. Cancer Lett 313(2):201–210
Zhu W, Wu S, Hannun YA (2017) Contributions of the intrinsic mutation process to cancer mutation and risk burdens. EBioMedicine 24:5–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Yadav, U.P. et al. (2022). Natural Compound-Based Nanoparticles to Target Free Radicals in Cancer. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-5422-0_276
Download citation
DOI: https://doi.org/10.1007/978-981-16-5422-0_276
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5421-3
Online ISBN: 978-981-16-5422-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences